Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wenfeng Gong
RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Cyclin D1 Induction by Benzo[a]pyrene-7,8-Diol-9,10-Epoxide via the Phosphatidylinositol 3-Kinase/Akt/Mapk- And P70s6k-Dependent Pathway Promotes Cell Transformation and Tumorigenesis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK
Clinical Cancer Research
Cancer Research
Oncology
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
Cancer Cell
Cancer Research
Oncology
Cell Biology
SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
The Intermediate-Activity L597VBRAF Mutant Acts as an Epistatic Modifier of Oncogenic RAS by Enhancing Signaling Through the RAF/MEK/ERK Pathway
Genes and Development
Genetics
Developmental Biology
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
Cancer Research
Cancer Research
Oncology
Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)
Oncology Letters
Cancer Research
Oncology
Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
MEK Inhibition Induces Differentiation in RAS-Driven Rhabdomyosarcoma
Cancer Discovery
Oncology
